Protherics PLC
Notification of Major Interests in Shares
London, UK; Brentwood, TN, US: 30 October 2007 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, announces that on 29 October 2007, in accordance with the
Transparency Obligations Directive, a notification of interest in the ordinary
share capital of the Company was received from AXA Investment Managers UK
Limited on behalf of AXA S.A. and its Group Companies ("AXA"). The notification
follows a decrease in the Indirect holding of AXA. Details of the interest
notified are as follows:
1. Reason for the notification (please tick the appropriate box or boxes)
A disposal of voting rights X
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):
2. Full name of person(s) subject to the AXA S.A., 25 Avenue Matignon, 75008 Paris and its
notification obligation: group of companies.
3. Full name of shareholder(s) (if different
from 2.):
4. Date of the transaction (and date on which 28 October 2007
the threshold is crossed or reached if
different):
5. Date on which issuer notified: 29 October 2007
6. Threshold(s) that is/are crossed or reached: 12%
7. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to Resulting situation after the triggering transaction
shares the Triggering
transaction
if possible using Number of Number of Number of Number of voting rights % of voting rights
the ISIN CODE Shares Voting shares
Rights Direct Direct Indirect Direct Indirect
0702920 41,502,097 41,502,097 741,666 741,666 40,684,681 0.22% 11.99%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting rights
instrument Period/ Date that may be acquired if
the instrument is
exercised/ converted.
Total (A+B)
Number of voting rights % of voting rights
41,426,347 12.21%
8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are
effectively held, if applicable :
Name of Company/Fund Number of Shares % of issued share capital
AXA UK Investment Co ICVC 527,152 0.15534
UK Smaller Companies Fund
Indirect
Sun Life Pensions Management Ltd 25,000 0.00737
Direct
AXA Sun Life 53,913 0.01589
FTSE All Share Tracker Life
Direct
AXA Sun Life 294,874 0.08689
FTSE All Share Tracker Pension
Direct
AXA Framlington 750,000 0.22101
SEI UK Equity
Indirect
AXA Framlington 854,587 0.25183
St James Place Exempt (Pens) Fund
Indirect
AXA Framlington 961,409 0.28331
St James Place Net (Life) Fund
Indirect
AXA Framlington 213,646 0.06296
St James Place Offshore Fund
Indirect
AXA Framlington 320,470 0.09444
Daimler Chrysler
Indirect
AXA Framlington 3,120,333 0.91951
Throgmorton Trust
Indirect
AXA Framlington 15,013,453 4.42422
UK Selet Ops
Indirect
AXA Framlington 13,753,131 4.05282
Equity Income
Indirect
AXA Framlington 2,000,000 0.58937
Managed Balanced
Indirect
AXA Framlington 1,500,000 0.44203
UK Smaller Companies
Indirect
AXA Framlington 500,000 0.14734
BAE Systems Pensions Fund CIF Trustees
Indirect
AXA Framlington 220,000 0.06483
BAE Systems 2000 Pensions Fund
Indirect
AXA Framlington onshore private clients 850,500 0.25063
Indirect
AXA Sun Life plc 226,817 0.06684
With Profit Transition Fund
Direct
Sun Life Assurance Society plc 141,062 0.04157
With Profit Transition Fund
Direct
AXA Framlington 100,000 0.02947
ST James Place Internal Equity & Income UT
Indirect
Total Direct 741,666 0.21856
Total Indirect 40,684,681 11.98912
TOTAL 41,426,347 12.20767
Proxy Voting:
9. Name of the proxy holder:
10. Number of voting rights proxy holder will cease to hold:
11. Date on which proxy holder will cease to hold voting
rights:
12. Additional information:
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
Protherics PLC announces Holding(s) in Company
| Source: Protherics PLC
Cheshire, UK--(Marketwire - October 30, 2007) -